Related Experiment Video
Updated: Jan 13, 2026

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model
Published on: February 8, 2022
Intracerebral Hemorrhage in Aging: Pathophysiology, Clinical Challenges, and Future Directions
Esra Zhubi1, Andrea Lehoczki2,3, Peter Toth2,3,4,5
1Department of Neurology, Semmelweis University, 1083 Budapest, Hungary.
Spontaneous intracerebral hemorrhage (ICH) and cerebral microbleeds (CMBs) are linked to aging, affecting older adults and contributing to cognitive decline. Understanding these aging-related mechanisms is key for developing new prevention and treatment strategies.
Area of Science:
- Neurology
- Gerontology
- Vascular Biology
Background:
- Spontaneous intracerebral hemorrhage (ICH) is a severe stroke type, common in older adults, leading to high mortality and cognitive impairment.
- Aging impacts cerebral vasculature, increasing susceptibility to ICH and cerebral microbleeds (CMBs), which share underlying pathological mechanisms.
- Cerebral microbleeds (CMBs) and ICH are part of a spectrum of hemorrhagic small vessel disease, contributing to vascular cognitive impairment and dementia (VCID).
Purpose of the Study:
- To review the cellular, molecular, and systemic factors driving ICH and CMBs in aging.
- To identify challenges in diagnosing and treating these conditions in older adults.
- To outline strategies for age-sensitive prevention and personalized care.
Main Methods:
- Literature review synthesizing current knowledge on aging-related ICH and CMBs.
- Analysis of pathophysiological mechanisms including endothelial dysfunction, impaired autoregulation, and inflammation.
- Examination of systemic factors like IGF-1 deficiency and their role in vascular vulnerability.
Main Results:
- Aging alters cerebral vasculature, promoting ICH and CMBs through mechanisms like endothelial dysfunction, impaired autoregulation, and inflammation.
- Age-related IGF-1 deficiency exacerbates microvascular vulnerability.
- CMBs and ICH are interconnected on a disease continuum, contributing significantly to VCID.
Conclusions:
- Older adults are underrepresented in clinical trials, necessitating age-specific research.
- Current therapeutic approaches inadequately address aging-related mechanisms driving ICH and CMBs.
- Developing individualized, age-sensitive strategies is crucial for preventing and managing these conditions.
More Related Videos
09:41Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
Published on: July 3, 2014
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Related Concept Videos
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Pharmacodynamics in Geriatric Patients: Effects of Age
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption